Lyrica generics roll: Pfizer blockbuster finally hits patent cliff

Pfizer's Lyrica has had a long, multibillion-dollar run. But now, that megablockbuster history is nearing its end. A slew of generics won FDA approval Friday, and they're revving up to race for the U.S. market.